The effect of vasopressin on choroidal blood flow, intraocular pressure, and orbital venous pressure in rabbits

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 10, 2011, Pages 7134-7140

  Bogner, Barbara ^a   Tockner, Birgit ^a   Runge, Christian ^a   Strohmaier, Clemens ^a   Trost, Andrea ^a   Branka, Manuela ^a   Radner, Wolfgang ^a   Kiel, Jeffrey W ^b   Schroedl, Falk ^a   Reitsamer, Herbert A ^a  

^a PARACELSUS MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ARTICLE; CHOROIDAL BLOOD FLOW; CONTROLLED STUDY; EYE BLOOD FLOW; FEMALE; HEART RATE; INTRAOCULAR PRESSURE; LASER DOPPLER FLOWMETRY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; VASCULAR RESISTANCE; VENOUS PRESSURE; ANIMAL; BLOOD FLOW; BLOOD PRESSURE; CHOROID; DOSE RESPONSE; DRUG EFFECT; INTRAVENOUS DRUG ADMINISTRATION; ORBIT; VASCULARIZATION;

ANIMALS; ARGININE VASOPRESSIN; BLOOD PRESSURE; CHOROID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; INFUSIONS, INTRAVENOUS; INTRAOCULAR PRESSURE; LASER-DOPPLER FLOWMETRY; MALE; ORBIT; RABBITS; REGIONAL BLOOD FLOW; VASOCONSTRICTOR AGENTS; VENOUS PRESSURE;

EID: 80155198957     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.11-7791     Document Type: Article

References (43)

1. Kiel JW. Modulation of choroidal autoregulation in the rabbit. Exp Eye Res. 1999;69:413-429.
2. Cioffi GA, Granstam E, Alm A. Ocular circulation. In: Kaufman PL, Alm A, eds. Adler's Physiology of the Eye: Clinical Application. St. Louis: Mosby; 2002:747-784.
3. Reitsamer HA, Zawinka C, Branka M. Dopaminergic vasodilation in the choroidal circulation by d1/d5 receptor activation. Invest Ophthalmol Vis Sci. 2004;45:900-905.
4. Flammer J, Orgul S, Costa VP, et al. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res. 2002;21:359-393.
5. Hof RP. Modification of vasopressin-and angiotensin II-induced changes by calcium antagonists in the peripheral circulation of anaesthetized rabbits. Br J Pharmacol. 1985;85:75-87.
6. Garcia-Villalon AL, Garcia JL, Fernandez N, Monge L, Gomez B, Dieguez G. Regional differences in the arterial response to vasopressin: role of endothelial nitric oxide. Br J Pharmacol. 1996;118:1848-1854.
7. Onoue H, Nakamura N, Toda N. Endothelium-dependent and _independent responses to vasodilators of isolated dog cerebral arteries. Stroke. 1988;19:1388-1394.
8. Okamura T, Toda M, Ayajiki K, Toda N. Receptor subtypes involved in relaxation and contraction by arginine vasopressin in canine isolated short posterior ciliary arteries. J Vasc Res. 1997; 34:464-472.
9. Nilsson SF. PACAP-27 and PACAP-38: vascular effects in the eye and some other tissues in the rabbit. Eur J Pharmacol. 1994;253: 17-25.
10. Gondim EL, Liu JH, Costa VP, Weinreb RN. Exogenous vasopressin influences intraocular pressure via the V(1) receptors. Curr Eye Res. 2001;22:295-303.
11. Krupin T, Webb GW, Barbosa AT, Gulli B, Levine J, Becker B. Central effects of thyrotropin-releasing hormone and arginine vasopressin on intraocular pressure in rabbits. Invest Ophthalmol Vis Sci. 1984;25:932-937.
12. Constant MA, Becker B. Experimental tonography, II: the effects of vasopressin, chlorpromazine, and phentolamine methanesulfonate. AMA Arch Ophthalmol. 1956;56:19-25.
13. Becker B, Christensen RE. Beta hypophamine (vasopressin), its effect upon intraocular pressure and aqueous flow in normal and glaucomatous eyes. AMA Arch Ophthalmol. 1956;56:1-9.
14. Reitsamer HA, Kiel JW. A rabbit model to study orbital venous pressure, intraocular pressure, and ocular hemodynamics simultaneously. Invest Ophthalmol Vis Sci. 2002;43:3728-3734.
15. Rohen JW. Ü ber das Gefäßsystem der Retina beim Kaninchen. Ophthalmologica. 1954;128:307-317.
16. Camras CB, Bito LZ. The pathophysiological effects of nitrogen mustard on the rabbit eye, II: the inhibition of the initial hypertensive phase by capsaicin and the apparent role of substance P. Invest Ophthalmol Vis Sci. 1980;19:423-428.
17. Neufeld AH, Jampol LM, Sears ML. Aspirin prevents the disruption of the blood-aqueous barrier in the rabbit eye. Nature. 1972;238: 158-159.
18. Sears ML. Miosis and intraocular pressure changes during manometry: mechanically irritated rabbit eyes studied with improved manometric technique. Arch Ophthalmol. 1960;63:707-714.
19. Hayreh SS, Zimmerman MB, Podhajsky P, Alward WL. Nocturnal arterial hypotension and its role in optic nerve head and ocular ischemic disorders. Am J Ophthalmol. 1994;117:603-624.
20. Leske MC, Wu S, Hennis A, et al. e. Risk factors for incident of open-angle glaucoma: the Barbados Eye Studies. Ophthalmology. 2008;115:85-93.
21. Schmetterer L, Garhofer G. How can blood flow be measured? Surv Ophthalmol. 2007;52(suppl 2):S134-S138.
22. Treschan TA, Peters J. The vasopressin system: physiology and clinical strategies. Anesthesiology. 2006;105:599-612.
23. Bourque CW, Oliet SH, Richard D. Osmoreceptors, osmoreception, and osmoregulation. Front Neuroendocrinol. 1994;15:231-274.
24. Thrasher TN. Baroreceptor regulation of vasopressin and renin secretion: low-pressure versus high-pressure receptors. Front Neuroendocrinol. 1994;15:157-196.
25. Petersen MB. The effect of vasopressin and related compounds at V1a and V2 receptors in animal models relevant to human disease. Basic Clin Pharmacol Toxicol. 2006;99:96-103.
26. Lemmens-Gruber R, Kamyar M. Vasopressin antagonists. Cell Mol Life Sci. 2006;63:1766-1779.
27. Trandafir CC, Nishihashi T, Wang A, Murakami S, Ji X, Kurahashi K. Participation of vasopressin in the development of cerebral vasospasm in a rat model of subarachnoid haemorrhage. Clin Exp Pharmacol Physiol. 2004;31:261-266.
28. Nishihashi T, Trandafir CC, Wang A, Ji X, Kurahashi K. Enhanced reactivity to vasopressin in rat basilar arteries during vasospasm after subarachnoid hemorrhage. Eur J Pharmacol. 2005;513:93-100.
29. Flammer J, Pache M, Resink T. Vasospasm, its role in the pathogenesis of diseases with particular reference to the eye. Prog Retin Eye Res. 2001;29:319-349.
30. Gasser P, Flammer J. Influence of vasospasm on visual function. Doc Ophthalmol. 1987;66:3-18.
31. Broadway DC, Drance SM. Glaucoma and vasospasm. Br J Ophthalmol. 1998;82:862-870.
32. Delaney Y, Walshe TE, O'Brien C. Vasospasm in glaucoma: clinical and laboratory aspects. Optom Vis Sci. 2006;83:406-414.
33. Ericsson BF. Effect of vasopressin on the distribution of cardiac output and organ blood flow in the anesthetized dog. Acta Chir Scand. 1971;137:729-738.
34. Friesenecker BE, Tsai AG, Martini J, et al. Arteriolar vasoconstrictive response: comparing the effects of arginine vasopressin and norepinephrine. Crit Care. 2006;10:R75.
35. Cowley AW Jr, Monos E, Guyton AC. Interaction of vasopressin and the baroreceptor reflex system in the regulation of arterial blood pressure in the dog. Circ Res. 1974;34:505-514.
36. Toda M, Ayajiki K, Okamura T, Azuma I, Toda N. Desmopressininduced dog ciliary artery relaxation. Eur J Pharmacol. 1998;344: 197-201.
37. Barrett LK, Singer M, Clapp LH. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med. 2007;35:33-40.
38. Leske MC, Heijl A, Hyman L, et al. Predictors of Long-term progression in the Early Manifest Glaucoma Trial. Ophthalmology. 2007;114.
39. Delgado TJ, Arbab MA, Warberg J, Svendgaard NA. The role of vasopressin in acute cerebral vasospasm: effect on spasm of a vasopressin antagonist or vasopressin antiserum. J Neurosurg. 1988;68:266-273.
40. Wallace I, Moolchandani J, Krupin T, Wulc A, Stone RA. Effects of systemic desmopressin on aqueous humor dynamics in rabbits. Invest Ophthalmol Vis Sci. 1988;29:406-410.
41. Lacheretz F, Barbier A, Serradeil-Le Gal C, Elena PP, Maffrand JP, Le Fur G. Effect of SR121463, a selective non-peptide vasopressin V2 receptor antagonist, in a rabbit model of ocular hypertension. J Ocul Pharmacol Ther. 2000;16:203-216.
42. Serradeil-Le Gal C. An overview of SR121463, a selective nonpeptide vasopressin V(2) receptor antagonist. Cardiovasc Drug Rev. 2001;19:201-214.
43. Ruskell G. Blood vessels of the orbit and globe. In: Prince J, ed. The Rabbit in Eye Research. Springfield, IL: Charles C. Thomas Publisher; 1964:514-553.